These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22339395)

  • 21. [Rituximab in treatment for neuroimmunological diseases].
    Schröder A; Ellrichmann G; Chehab G; Schneider M; Linker RA; Gold R
    Nervenarzt; 2009 Feb; 80(2):155-6, 158-60, 162-5. PubMed ID: 19183926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel medical treatment modalities in hematology].
    Hasselbalch HC; Birgens H; Dufva IH; Dalseg AM; Brown Pde N; Jensen MK; Vangsted A
    Ugeskr Laeger; 2008 Jun; 170(24):2115-9. PubMed ID: 18565291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.
    Hainsworth JD
    Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S12-6. PubMed ID: 15180892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
    Mease PJ
    J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
    King KM; Younes A
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GA-101, a third-generation, humanized and glyco-engineered anti-CD20 mAb for the treatment of B-cell lymphoid malignancies.
    Robak T
    Curr Opin Investig Drugs; 2009 Jun; 10(6):588-96. PubMed ID: 19513948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab in chronic lymphocytic leukemia.
    Jaglowski SM; Byrd JC
    Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies for B-cell lymphomas: rituximab and beyond.
    Bello C; Sotomayor EM
    Hematology Am Soc Hematol Educ Program; 2007; ():233-42. PubMed ID: 18024635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD20 antibody treatment of non-Hodgkin lymphomas.
    Engelhard M
    Clin Immunol; 2016 Nov; 172():101-104. PubMed ID: 27531574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody].
    Tobinai K
    Nihon Rinsho; 2002 Mar; 60(3):468-72. PubMed ID: 11904960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel uses of rituximab].
    Frenzel L
    Rev Prat; 2013 Dec; 63(10):1349-53. PubMed ID: 24579323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on rituximab: an established treatment for all immune-mediated kidney diseases?
    Evans R; Salama AD
    Nephron Clin Pract; 2014; 126(3):97-109. PubMed ID: 24686110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab and its use in autoimmune bullous disorders.
    Daniel BS; Murrell DF; Joly P
    Immunol Allergy Clin North Am; 2012 May; 32(2):331-7, viii. PubMed ID: 22560146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rituximab and hematological malignancy].
    Hatake K; Mishima Y; Terui Y
    Nihon Rinsho; 2004 Jul; 62(7):1321-4. PubMed ID: 15283150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders.
    Musto P; D'Auria F
    Expert Opin Biol Ther; 2011 May; 11(5):551-7. PubMed ID: 21385115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab in the treatment of autoimmune haematological disorders.
    Garvey B
    Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in B-cell chronic lymphocytic leukemia.
    Lin TS; Lucas MS; Byrd JC
    Semin Oncol; 2003 Aug; 30(4):483-92. PubMed ID: 12939717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.